Dimension (Science and Technology)

Dimension is a multistage, stage-agnostic investment firm that partners with founders working at the frontiers of science and compute. Its investment focus sits at the convergence of technology, machine learning, and the life sciences, spanning domains that include machine learning, biotechnology, computational science, software infrastructure, and laboratory tools and instruments. The firm is based in New York.

The firm operates a research arm, Dimension Research, through which the team develops investment theses and publishes analysis on frontier advances in life sciences, machine learning, and technology. This research-led approach underpins a thesis-driven investment process: positions are informed by written analysis of scientific and technical developments rather than by sector screening alone. The stated culture is interdisciplinary, emphasising collaboration across biology, chemistry, physics, and computational science.

Dimension's stage-agnostic posture means it can partner with companies across stages rather than at a fixed point in the financing lifecycle. Its stated areas of interest - biotechnology, life sciences, machine learning, software infrastructure, and laboratory tools and instruments - describe a portfolio pattern centred on the overlap of scientific instrumentation, computational method, and applied machine learning. Founding year, team size, fund size, and check size are not disclosed.